541 related articles for article (PubMed ID: 25339825)
1. Recent advances in the surgical treatment of hepatocellular carcinoma.
Morise Z; Kawabe N; Tomishige H; Nagata H; Kawase J; Arakawa S; Yoshida R; Isetani M
World J Gastroenterol; 2014 Oct; 20(39):14381-92. PubMed ID: 25339825
[TBL] [Abstract][Full Text] [Related]
2. Current surgical treatment strategies for hepatocellular carcinoma in North America.
Khan AS; Fowler KJ; Chapman WC
World J Gastroenterol; 2014 Nov; 20(41):15007-17. PubMed ID: 25386049
[TBL] [Abstract][Full Text] [Related]
3. HCC: current surgical treatment concepts.
Cauchy F; Fuks D; Belghiti J
Langenbecks Arch Surg; 2012 Jun; 397(5):681-95. PubMed ID: 22290218
[TBL] [Abstract][Full Text] [Related]
4. Survival analysis of patients with stage I and II hepatocellular carcinoma after a liver transplantation or liver resection.
Seshadri RM; Besur S; Niemeyer DJ; Templin M; McKillop IH; Swan RZ; Martinie JB; Russo MW; Iannitti DA
HPB (Oxford); 2014 Dec; 16(12):1102-9. PubMed ID: 24964271
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the current surgical strategies for hepatocellular carcinoma.
Takamoto T; Sugawara Y; Hashimoto T; Makuuchi M
Expert Rev Gastroenterol Hepatol; 2016; 10(3):341-57. PubMed ID: 26558422
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.
Kim JM; Kwon CH; Joh JW; Choi MS; Lee JH; Koh KC; Paik SW; Kim GS; Kim SJ; Lee SK; Yoo BC
Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma downstaging in liver transplantation.
Yu CY; Ou HY; Huang TL; Chen TY; Tsang LL; Chen CL; Cheng YF
Transplant Proc; 2012 Mar; 44(2):412-4. PubMed ID: 22410030
[TBL] [Abstract][Full Text] [Related]
8. Section 2. Small-for-size liver graft and hepatocellular carcinoma recurrence.
Chan SC
Transplantation; 2014 Apr; 97 Suppl 8():S7-S10. PubMed ID: 24849840
[TBL] [Abstract][Full Text] [Related]
9. Survival Benefit of Liver Transplantation Versus Resection for Hepatocellular Carcinoma: Impact of MELD Score.
Vitale A; Huo TL; Cucchetti A; Lee YH; Volk M; Frigo AC; Cescon M; Tuci F; Pinna AD; Cillo U
Ann Surg Oncol; 2015; 22(6):1901-7. PubMed ID: 25234023
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma: resection versus transplantation.
Earl TM; Chapman WC
Semin Liver Dis; 2013 Aug; 33(3):282-92. PubMed ID: 23943108
[TBL] [Abstract][Full Text] [Related]
11. Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation.
Cherqui D; Laurent A; Mocellin N; Tayar C; Luciani A; Van Nhieu JT; Decaens T; Hurtova M; Memeo R; Mallat A; Duvoux C
Ann Surg; 2009 Nov; 250(5):738-46. PubMed ID: 19801927
[TBL] [Abstract][Full Text] [Related]
12. Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation.
Margarit C; Escartín A; Castells L; Vargas V; Allende E; Bilbao I
Liver Transpl; 2005 Oct; 11(10):1242-51. PubMed ID: 16184539
[TBL] [Abstract][Full Text] [Related]
13. Living donor liver transplantation for hepatocellular carcinoma: the impact of neo-adjuvant treatments on the long term results.
Di Sandro S; Giacomoni A; Slim A; Lauterio A; Mangoni I; Mihaylov P; Pirotta V; Aseni P; De Carlis L
Hepatogastroenterology; 2012; 59(114):505-10. PubMed ID: 22353516
[TBL] [Abstract][Full Text] [Related]
14. Single HCC in cirrhotic patients: liver resection or liver transplantation? Long-term outcome according to an intention-to-treat basis.
Sapisochin G; Castells L; Dopazo C; Bilbao I; Minguez B; Lázaro JL; Allende H; Balsells J; Caralt M; Charco R
Ann Surg Oncol; 2013 Apr; 20(4):1194-202. PubMed ID: 22965574
[TBL] [Abstract][Full Text] [Related]
15. Necrosis percentage of radiologically treated hepatocellular carcinoma at hepatectomy for liver transplantation.
Rossetto A; Adani GL; Baccarani U; Bresadola V; Lorenzin D; Sponza M; Vit A; De Anna D; Bresadola F
Transplant Proc; 2011 May; 43(4):1095-7. PubMed ID: 21620061
[TBL] [Abstract][Full Text] [Related]
16. Living donor liver transplantation or resection for Child-Pugh A hepatocellular carcinoma patients with multiple nodules meeting the Milan criteria.
Jiang L; Liao A; Wen T; Yan L; Li B; Yang J
Transpl Int; 2014 Jun; 27(6):562-9. PubMed ID: 24606007
[TBL] [Abstract][Full Text] [Related]
17. Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation.
Pompili M; Francica G; Ponziani FR; Iezzi R; Avolio AW
World J Gastroenterol; 2013 Nov; 19(43):7515-30. PubMed ID: 24282343
[TBL] [Abstract][Full Text] [Related]
18. Current role of surgery in treatment of early stage hepatocellular carcinoma: resection versus liver transplantation.
Yi NJ; Suh KS; Kim T; Kim J; Shin WY; Lee KU
Oncology; 2008; 75 Suppl 1():124-8. PubMed ID: 19092282
[TBL] [Abstract][Full Text] [Related]
19. Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma.
Lee KK; Kim DG; Moon IS; Lee MD; Park JH
J Surg Oncol; 2010 Jan; 101(1):47-53. PubMed ID: 19798686
[TBL] [Abstract][Full Text] [Related]
20. Wait and transplant for stage 2 hepatocellular carcinoma with deceased-donor liver grafts.
Chan SC; Sharr WW; Chok KS; Chan AC; Lo CM
Transplantation; 2013 Dec; 96(11):995-9. PubMed ID: 23924774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]